BerGenBio

Director's Dealing • Jan 6, 2022

BerGenBio - Mandatory notification of trade by Primary Insiders

BerGenBio - Mandatory notification of trade by Primary Insiders

Bergen, Norway,6 January 2022?-BerGenBioASA (OSE: BGBIO) (the "Company"), has

been notified that Martin Olin, CEO and primary insider of BerGenBio ASA, has

bought 8,000 shares in BerGenBio ASA at an average price of NOK 19.87 per share.

After the transaction Mr. Olin holds 8,000 shares in BerGenBio ASA.

Please see the attached document for further details of the transaction.

Contact:

ir@bergenbio.com

RuneSkeie, CFO,BerGenBioASA

rune.skeie@bergenbio.com

This information issubject to the disclosure requirements pursuant to the EU

Market Abuse Regulation (MAR) and section 5-12 of the Norwegian Securities

Trading Act.